Quarterly report · Q2
2413.TEDINET S100PJMD
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥112.6bn | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥55.6bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥208.2bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥97.6bn | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥51.2bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥36.3bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥17.6bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥61.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥37.3bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥38.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥18.3bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥96.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥62.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥37.5bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥24.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥11.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥63.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥40.8bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥25.0bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥26.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥12.5bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥42.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥25.8bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥377.7bn | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥346.0bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥308.4bn | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥86.4bn | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥82.0bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥291.3bn | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥237.7bn | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥207.3bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥284.5bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥257.8bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥231.4bn | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥100.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥87.0bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥89.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥25.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥52.1bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥18.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥18.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥8.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥14.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥16.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥13.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥35.44 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥17.58 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥94.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥60.09 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥36.86 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥35.42 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥17.57 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥93.98 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥60.04 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥36.83 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 75.3% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.0% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 107
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥701m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥231m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥8.4bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥445m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥179m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥634m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥14.0bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥6.8bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.7bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥6.6bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥347m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥185m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥42.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥22.3bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥40.9bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥664m |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥18.8bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥10.0bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥30.2bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥30.2bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥8.1bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥18.8bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥8.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥18.5bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥8.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥304m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥865m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥113.9bn |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥55.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥111.2bn |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥54.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥1.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥36.9bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥17.6bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥1.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥1.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥520m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥376m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥8.2bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥7.8bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥364m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥338m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥979m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥10.1bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥5.3bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.6bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥483m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥288m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥38.4bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥19.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥37.1bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥18.8bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥622m |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥16.7bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥8.5bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥24.4bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥24.4bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥12m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥38.1bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥25.2bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥17.5bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥12.2bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥11.9bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥238m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥238m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥2.0bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥98.6bn |
| —segment total | revenue | 2021-07-01 → 2021-09-30 | ¥52.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥96.2bn |
| —segment total | revenue external | 2021-07-01 → 2021-09-30 | ¥50.5bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2.4bn |
| —segment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥1.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥62.9bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥37.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 824
| Item | Context | Value | Unit |
|---|---|---|---|
| Treasury shares IFRS | Prior1YearInstant | -36000000 | JPY |
| Treasury shares IFRS | CurrentQuarterInstant | -37000000 | JPY |
| Other components of equity IFRS | Prior1YearInstant | 6131000000 | JPY |
| Other components of equity IFRS | CurrentQuarterInstant | 19447000000 | JPY |
| Retained earnings IFRS | Prior1YearInstant | 192912000000 | JPY |
| Retained earnings IFRS | CurrentQuarterInstant | 206160000000 | JPY |
| Equity attributable to owners of parent IFRS | Prior1YearInstant | 257840000000 | JPY |
| Equity attributable to owners of parent IFRS | CurrentQuarterInstant | 284479000000 | JPY |
| Non controlling interests IFRS | Prior1YearInstant | 6113000000 | JPY |
| Non controlling interests IFRS | CurrentQuarterInstant | 6827000000 | JPY |
| Equity IFRS | Prior1YearInstant | 263954000000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 291306000000 | JPY |
| Liabilities and equity IFRS | Prior1YearInstant | 345981000000 | JPY |
| Liabilities and equity IFRS | CurrentQuarterInstant | 377747000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 97647000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 112616000000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 40299000000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 47380000000 | JPY |
| Gross profit IFRS | Prior1YTDDuration | 57348000000 | JPY |
| Gross profit IFRS | CurrentYTDDuration | 65237000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YTDDuration | 26674000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYTDDuration | 30911000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | -462000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | 614000000 | JPY |
| Gain relating to loss of control over subsidiaries IFRS | Prior1YTDDuration | 9443000000 | JPY |
| Gain relating to loss of control over subsidiaries IFRS | CurrentYTDDuration | － | JPY |
| Gain on change in equity IFRS | Prior1YTDDuration | 21906000000 | JPY |
| Gain on change in equity IFRS | CurrentYTDDuration | － | JPY |
| Other income IFRS | Prior1YTDDuration | 455000000 | JPY |
| Other income IFRS | CurrentYTDDuration | 1477000000 | JPY |
| Other expenses IFRS | Prior1YTDDuration | 77000000 | JPY |
| Other expenses IFRS | CurrentYTDDuration | 124000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 61941000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 36293000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 320000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 1806000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 29000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 32000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 62232000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 38067000000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 19485000000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | 12101000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 42747000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 25966000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | 40788000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | 24060000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YTDDuration | 1958000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYTDDuration | 1906000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 42747000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 25966000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |